Content warning: drug addiction, mental illness, disability
I remember the hot summer afternoon in July 2007 when I injured my back. It was a day that would change my life. I was 18, and taking part in a military program to qualify as a professional infantry soldier in the Canadian Armed Forces. My injuries all started during the first phase of a 10-kilometer walk, while carrying a 40-pound rucksack. As training progressed, I began to feel an odd sense of discomfort in my lower back. After I returned to my dorm later that day and unstrapped the rucksack, I felt a sharp pain going down from my lower back to my leg. Before bed, I took a couple of aspirin pills and washed them down with gin. The next morning, the pain had partly subsided, but the discomfort and feeling that something was wrong with my back stuck with me for days after. Weeks later, during another military exercise with a rucksack, I hurt my back so severely that I needed to see the nurse. At the time, I did not know that the following ten years would be comprised of pain from the moment I wake up to the moment I go to bed. This was the beginning of my struggle with chronic pain. Since then, I have been trying to find a way to cure my back, leading me to try regenerative medicine treatments such as Platelet Rich Plasma (PRP) and stem cells.
For the past ten years, Ive seen chiropractors, physiotherapists, psychiatrists, rheumatologists, osteopaths and virtually every health professional to treat my injury. I tried decompression therapy, kinesiotherapy, swimming, physiotherapy, non-steroidal anti-inflammatories drugs (NSAIDs), steroid injections, oral steroids, acupuncture, Chinese therapeutic massage, and praying but nothing worked. After various treatments fell through, what made the journey of searching for a cure even more difficult was the general apathy from medical doctors in Canada. Some medical specialists thought that the extent of my injury did not match the severity of the pain, therefore, my pain was merely an illusion. They dismissed my medical condition and recommended that I swim more or become more physically active. While some doctors believed me, they still didnt know how to help me. For almost eight years, I fought an uphill battle trying to convince medical professionals that I was worth their time and that I needed help. This struggle profoundly impacted my mental health.
I was stuck in a prison of pain from which I could not escape. 6 years after the injury, the pain has grown into a disability. There were days when I could barely walk or sit down for more than a few minutes. At times, my life felt like a nightmare. Activities most people take for granted, such as showering or cleaning a room, quickly became strenuous for me. Chronic pain also started impacting other areas of my life; my studies, my work, and even my relationships. I almost failed my first year of law school because of chronic pain. It made me start drinking again, and it put me into a state where I was consumed by narcotics and depression. After years of feeling despair and being unable to find an effective treatment through Canadas healthcare system, I started looking into private medical practice in the US in 2015.
Regenokine
In January of 2016, I went to New York, where I had my first experience with regenerative medicine. I went to NY Spine Medicine to get the same treatment that Kobe Bryant had received for his knees a few years back in 2013 Regenokine.
Regenokine is an anti-inflammatory serum made from the patients blood to suppress back and joint pain. The serum is made by taking some of the patients blood, heating it, and incubating it with zinc etched with glass beads. It is believed that the serum becomes rich in Interleukin 1 Receptor Antagonist Protein (IRAP), which is a natural anti-inflammatory. According to the medical doctors from NY Spine Clinic, once the serum is injected at the site of injury, it reduces the inflammation and speeds up the bodys own healing mechanism. Its as if you had a strong dose of Tylenol directly injected in an ankle or your back.
The treatment is recent; it was first developed by a doctor in Dusseldorf, Germany around 15 years ago. NY Spine Medicine is one of the institutes in the US that offer this treatment, and the cost of it is obscenely high. The treatment cost me around 17,000 US dollars for four consecutive days of injections.
I had around about 600 ml of blood taken out, and in the next four days had the serum re-injected into my lower back: facet joints, epidural space, and all around the lower spine. At the beginning of my treatment, the pain was at an all-time high and I could barely sit for more than 5 minutes. Every day of injections resulted in more and more of the pain dissipating. On the last day, before my last round of injections, I woke up pain-free for the first time in years. Shaken by the relief and emotions, I started crying I could not believe how good it felt to be free of pain. It was a miracle, but a short-lived one: the pain-relieving effects of the treatment only lasted for two months before my back started hurting once again.
Platelet Rich Plasma (PRP)
Few months passed after the Regenokine treatment and the memory of being pain-free started to fade away, but I still had hope. I kept dreaming of finding another treatment that could heal me completely. I began researching alternative treatments and eventually found the Centeno-Schultz Clinic in Colorado; they used Platelet Rich Plasma (PRP) and stem cells to treat back pain.
My first treatment at the clinic was an injection of PRP in my lower back, neck, and hips. PRP is very similar to Regenokine in that it is an autologous serum it is made with the patients blood. The difference is that while Regenokine works as an anti-inflammatory, the process by which PRP works is inflammatory. The doctor who treated me explained that PRP forces the body into a super inflammatory state, and as the inflammation subsides, it accelerates the reconstruction of ligaments and other tissues, which would in turn ease the pain. I had PRP injected into my sacroiliac joint, my lower back epidural space, and everywhere around my facet joints in my neck and back. In the first few days after the treatment, my pain levels flared up. However, in the next few weeks, the pain went down progressively, and I regained some degree of mobility. The most dramatic change was in my neck: the pain level went from a high 6-7 out of 10 to nearly a 1 within a few days. After a month, my lower back and hips felt as if they were almost healed. Although the effect of the treatment was not as dramatic as Regenokine, it lasted for a few months. I went from limping and barely being able to function to being able to play sports and go to class again. Unfortunately, like Regenokine, the healing effects of PRP were temporary. The treatment cost me around 10,000 US dollars.
Stem cells
Stem cell treatment was my last hope with regards to regenerative medicine. On May 28, I flew to the Cayman Islands for my stem cell treatment with a clinic affiliated with Centeno-Schultz Clinic. Like PRP and Regenokine, the stem cell treatment was autologous. I had three huge syringes of bone marrow aspirated from my hip bone. Mesenchymal stem cells were extracted from the bone marrow and cultivated to grow. Mesenchymal stem cells are multipotent stem cells that can transform into different types of cells depending on the situation. In my case, the stem cells were injected inside of my L5-S1 intervertebral disc with the hope that they would transform into disc tissue and help my lumbar spine heal.
The first few days after the operation, the pain was almost unbearable without oxycodone, a narcotic. It was nearly impossible to walk, bend forward, or even dress myself. The doctor informed me that I would see my pain flare up in the following four weeks, but in time, I would regain range of motion. I was also told that eventually my body is likely to be healed a hundred percent. The results are promising thus far. It has been almost three weeks since the treatment, and I have already gained back mobility and functionality. There is something changing in my back. I used to be in pain from morning to night, now after a good night of sleep, I usually wake up free from pain. In the morning, there is slight discomfort in my hip and lower back area, but no pain until I move too much or sit for too long. It takes four to six months to evaluate the full result, which seem hopeful. The stem cell treatment for my lower back and hip cost 29,000 US dollars.
Regenerative medicine does work amazingly well, but its drawback is in its exorbitant price and inaccessibility in Canada. I believe regenerative treatment is the future of medicine, and hope that the three treatments are made available in Canada as soon as possible. In total, I spent over 70,000 Canadian dollars just for my three treatments. No one should have to pay that much to live free of pain. Health is crucial to happiness, and it should never be the privilege to the only few who can afford expensive medical trips abroad.
An earlier version of this article stated thatNY Spine Medicine is the only institute in the US that offers Regenokine. In fact, there are other institutes in the US that offer the treatment. The Daily regrets the error.
Sami Ellaia is a 3L student at the Faculty of Law. To reach him, please contact sami.ellaia@mail.mcgill.ca.
The rest is here:
Scitech | My experience with regenerative medicine - The McGill Daily (blog)
- Navigating the hope and hype of regenerative medicine - October 14th, 2024
- Cell and Gene Therapy Investment Ticks Up After Hard Few Years - BioSpace - October 14th, 2024
- Crackdowns on Unproven Stem Cell Therapies Worked Abroad - Medpage Today - October 14th, 2024
- How Regenerative Medicine can help you get out of pain without surgery - WJLA - October 14th, 2024
- Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care... - October 14th, 2024
- Buy, Sell, Hold: Cell and Gene Therapy - BioPharm International - October 14th, 2024
- Mayo Clinic offers unique regenerative medicine procedure for knee and ... - September 13th, 2024
- Regenerative Medicine to the Rescue - Cleveland Clinic - September 13th, 2024
- Regenerative medicine applications: An overview of clinical trials - September 13th, 2024
- The Progression of Regenerative Medicine and its Impact on Therapy ... - September 13th, 2024
- Immune cell injection significantly boosts healing of bone, muscle & skin - September 13th, 2024
- Regenerative Medicine Foundation - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT ... - September 13th, 2024
- Tissue engineering and regenerative medicine approaches in colorectal ... - September 13th, 2024
- Tubular scaffolds boost stem cell-driven bone regeneration in skull defects - Phys.org - September 13th, 2024
- Finding the right path(way) to reduce fat accumulation in the liver - Medical University of South Carolina - September 13th, 2024
- NAMRU EURAFCENT Signs Agreement with Egypt Center for Research and Regenerative Medicine - DVIDS - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program - StockTitan - September 13th, 2024
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and... - September 13th, 2024
- Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate - Yahoo Finance - September 13th, 2024
- Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets - Nature.com - September 13th, 2024
- Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Business Wire - September 13th, 2024
- HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials - Longview News-Journal - September 13th, 2024
- Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma -... - September 4th, 2024
- Regenerative Medicine in Orthopedic Surgery: Expanding Our Toolbox - Cureus - September 4th, 2024
- Somite.ai takes pre-seed to $10M as it eyes to become the OpenAI of stem cell biology - CTech - September 4th, 2024
- Longeveron Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B in Hypoplastic Left Heart Syndrome (HLHS) - Yahoo... - September 4th, 2024
- Study Explores Potential Of 3D Printed Regenerative Breast Implants - Forbes - September 4th, 2024
- Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine - PR... - September 4th, 2024
- Trinity researcher scores 800,000 to boost regenerative medicine - SiliconRepublic.com - September 4th, 2024
- Seeing the future: Zebrafish regenerates fully functional photoreceptor cells and restores its vision - EurekAlert - September 4th, 2024
- Regenerative Medicine Industry Projected to Surge to USD 73,084.2 Million by 2033, Growing at an 18.5% CAGR - Future Market Insights - September 4th, 2024
- What is regenerative medicine? | Northwell Health - July 2nd, 2024
- Science Saturday: A regenerative reset for aging - July 2nd, 2024
- Science Saturday: A year of new directions and advancements for ... - March 29th, 2024
- Diverse ways regenerative medicine is advancing health care - March 29th, 2024
- Stem cell-based regenerative medicine - PMC - National Center for ... - February 27th, 2024
- Regenerative medicine | NIST - February 10th, 2024
- San Jose blood stem cell donor meets 15-year-old whose life he saved in Los Angeles - The Mercury News - May 17th, 2023
- Regenerative medicine: Current therapies and future directions - April 23rd, 2023
- What Is Regenerative Medicine? | Goals and Applications | ISCRM - April 23rd, 2023
- Important Patient and Consumer Information About Regenerative Medicine ... - April 23rd, 2023
- Regenerative medicine can be a boon for those with Drug-Resistant Tuberculosis - Hindustan Times - April 23rd, 2023
- About Regenerative Medicine - Center for Regenerative ... - Mayo Clinic - April 7th, 2023
- Regenerative Medicine | National Institutes of Health (NIH) - April 7th, 2023
- Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50%during the forecast - EIN News - April 7th, 2023
- Advancing Safe and Effective Regenerative Medicine Products - March 21st, 2023
- Active Wound Care Market Rising demand for Skin Substitutes to boost the industry (2023-2033) | CAGR of 5.5% - EIN News - March 21st, 2023
- Veterinary Orthopedic Implants Market is estimated to be 421.3 Million by 2029 with a CAGR of 5.3% - By PMI - EIN News - March 21st, 2023
- ASKA Pharmaceutical : February 7 2023 EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical VHH to address an unmet medical... - February 8th, 2023
- A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field - Yahoo Finance - October 15th, 2022
- The Switch to Regenerative Medicine - Dermatology Times - October 15th, 2022
- The Alliance for Regenerative Medicine Announces Election of 2023 Officers, Executive Committee, and Board of Directors - GlobeNewswire - October 15th, 2022
- Mathematical model could bring us closer to effective stem cell therapies - Michigan Medicine - October 15th, 2022
- 'We have to find a way': FDA seeks solutions to aid bespoke gene therapy - BioPharma Dive - October 15th, 2022
- American Academy of Stem Cell Physicians to Offer Licensed Physicians Board Examination in Regenerative Medicine - GlobeNewswire - October 15th, 2022
- Discover Medical Advances in Cellular Therapy Research Using Cord Blood for Cancer, HIV, Cerebral Palsy and Autism During World Cord Blood Day 2022 -... - October 15th, 2022
- The Risk-Reward Proposition for CGT Clinical Trials - Applied Clinical Trials Online - October 15th, 2022
- Cell therapy weekly: Ray Therapeutics and Forge Biologics expand partnership - RegMedNet - October 15th, 2022
- FDA Expands Oversight of Cell and Gene Therapies - Pharmaceutical Technology Magazine - October 15th, 2022
- Frequency Therapeutics Completes Enrollment of Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss - Business Wire - October 15th, 2022
- The Health Benefits Of Sea Moss, According To Experts - Forbes - October 15th, 2022
- ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of ... - The Bakersfield Californian - October 15th, 2022
- Pain Management & Regenerative Medicine Specialists DFW - September 4th, 2022
- Tissue Engineering and Regenerative Medicine - National Institute of ... - September 4th, 2022
- First U.S. patient receives autologous stem cell therapy to treat dry AMD - National Institutes of Health (.gov) - September 4th, 2022
- International Stem Cell and Regenerative Medicine Research and Therapeutic Center in Egypt - Construction Review - September 4th, 2022
- Regenerative Medicine Market to Garner Bursting Revenues [+USD 27.29 Billion] with Top Growing Companies During 2022-2029 - eTurboNews | eTN - September 4th, 2022
- Immusoft Takes First-Ever Engineered B Cell Therapy into Clinic - BioSpace - September 4th, 2022
- Addressing Diversity Barriers to Regenerative Medicine Free Press of Jacksonville - Jacksonville Free Press - September 4th, 2022
- TikoMed's ILB mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all... - September 4th, 2022
- Frequency Therapeutics to Participate in September Investor and Medical Conferences - Business Wire - September 4th, 2022
- Can the immortal jellyfish teach us how to reverse aging? - Earth.com - September 4th, 2022
- Applied StemCell Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy - Business Wire - September 4th, 2022
- Omega Therapeutics Announces Appointment of Rainer Boehm to its Board of Directors - PR Newswire - September 4th, 2022
- Rise In Number Of CROS In Various Regions Such As Europe Is Expected To Fuel The Growth Of Induced Pluripotent Stem Cell Market At An Impressive CAGR... - September 4th, 2022
- Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide - ResearchAndMarkets.com -... - August 19th, 2022
- Pain Relief Treatments: The Benefits of Regenerative Medicine From Head to Toe - 30Seconds.com - August 19th, 2022
- FDA Issues Draft Guidance to Facilitate Development of Human Gene Therapy, CAR T Cell, and Regenerative Medicine Products - Wilson Sonsini Goodrich... - August 19th, 2022
- Marco Quarta to present at the 9th Aging Research & Drug Discovery Meeting 2022 - EurekAlert - August 19th, 2022